Stay updated on Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial
Sign up to get notified when there's something new on the Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial page.

Latest updates to the Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial page
- ChecktodayChange DetectedThe website footer now displays software revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears on the page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check28 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study history now shows a new Revision: v3.7.0, replacing the previous revision label. This signals an updated version of the study record.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision label v3.6.6 was added to the Study Record History, and the previous revision v3.6.5 was removed, representing an update to the record's metadata.SummaryDifference0.1%

- Check84 days agoChange DetectedThe study record history now shows a new Revision: v3.6.5, replacing Revision: v3.6.4; this indicates a minor version update to the page rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial page.